Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? Yes
Write-up: Information has been received from a physician concerning a 23 weeks old male with no allergies, who on 19-OCT-2009 was vaccinated with a first dose of ROTATEQ (lot number: 664070/0320Y, route not reported, expiration date: 19-OCT-2009). On 17-DEC-2009 the patient was vaccinated with a second dose of ROTATEQ (lot number: 664291/0769Y and route not reported, expiration date: 27-JAN-2009). The physician reported that the patient developed intussusception after his second dose of ROTATEQ and was hospitalized on 30-JAN-2010 with severe dehydration and was kept in the hospital until his discharge on 01-FEB-2010. The physician stated that "the patient continued to improve after discharge from the hospital and soon felt 100% better. Complete blood count and an ultrasound were performed when the patient was admitted on 30-JAN-2010 to confirm his diagnosis. Also the physician stated that "there were no plans to give the patient third dose of ROTATEQ". Therapy with ROTATEQ was discontinued on 17-DEC-2009. Intussusception and severe dehydration were considered to be immediately life-threatening. Additional information has been requested.
Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166